To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
The Associated Press Kamila Valieva, of the Russian Olympic Committee, competes in the women’s team free skate program during the figure skating competition at the 2022 Winter Olympics, on Monday n Beijing.
The Associated Press
9:41 JST, February 10, 2022
BEIJING (AP) — Olympic favorite Kamila Valieva tested positive for a banned heart medication before her arrival at the Beijing Olympics, the Russian newspaper RBC reported, putting in jeopardy the team gold medal that she helped win earlier this week.
The sample was reportedly obtained in December, when the 15-year-old Valieva was still in Russia but did not come to light until after she had helped her team win the gold medal with dynamic performances in her short program and free skate.
The drug, Trimetazidine, is used to to treat angina — a type of chest pain marked by reduced blood flow to the heart — and is banned by the World Anti-Doping Agency as a stimulant. It is the same drug that was involved in a Russian bobsled case at the 2018 Olympics that ended in a settlement and the athletes accepting an eight-month ban.
It is unclear whether Valieva has any heart problems.
